Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N -Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

(2017) J.M. Witkin et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

(2017) Mark D. Berry et al.   PHARMACOLOGY & THERAPEUTICS

Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats

(2016) Magdalena Jastrzębska-Więsek et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats

(2016) Antonio Ferragud et al.   NEUROPSYCHOPHARMACOLOGY

Incretin-like effects of small molecule trace amine-associated receptor 1 agonists

(2016) Susanne Raab et al.   Molecular Metabolism

Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers

(2015) Anja Harmeier et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

(2015) Stefano Espinoza et al.   NEUROPHARMACOLOGY

Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds

(2015) Yue Pei et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats

(2014) Hiroyuki Koike et al.   BEHAVIOURAL BRAIN RESEARCH

Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors

(2014) D. Leo et al.   NEUROPHARMACOLOGY

Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2

(2013) A. Babusyte et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

(2013) Caroline A. Browne et al.   Frontiers in Pharmacology

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

(2012) F G Revel et al.   MOLECULAR PSYCHIATRY

BRET biosensors to study GPCR biology, pharmacology, and signal transduction

(2012) Ali Salahpour   Frontiers in Endocrinology

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

(2011) S. Espinoza et al.   MOLECULAR PHARMACOLOGY

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator

(2010) Tatyana D. Sotnikova et al.   PLoS One

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

(2010) Shikha Snigdha et al.   PSYCHOPHARMACOLOGY

Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor

(2008) L. S. Barak et al.   MOLECULAR PHARMACOLOGY